国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2011年
1期
48-51
,共4页
食管肿瘤%放射治疗剂量
食管腫瘤%放射治療劑量
식관종류%방사치료제량
Esophageal neoplasms%Radiotherapy dosage
食管癌确诊时中晚期患者较多,即使行根治性手术切除者其5年生存率也仅20%～30%,术后放疗是重要的辅助治疗和补救治疗手段,但是关于术后放疗的适应证、术后放疗照射范围及合适剂量目前均尚无统一的明确的界定.
食管癌確診時中晚期患者較多,即使行根治性手術切除者其5年生存率也僅20%～30%,術後放療是重要的輔助治療和補救治療手段,但是關于術後放療的適應證、術後放療照射範圍及閤適劑量目前均尚無統一的明確的界定.
식관암학진시중만기환자교다,즉사행근치성수술절제자기5년생존솔야부20%～30%,술후방료시중요적보조치료화보구치료수단,단시관우술후방료적괄응증、술후방료조사범위급합괄제량목전균상무통일적명학적계정.
Among esophageal cancer patients who had undergone radical surgery, the overall 5-year survival rate ranges from 20% to 30%. Postoperative radiotherapy is important adjunctive and remedial treatment. However, currently, there is no clear consensus on the indication of postoperative radiotherapy, the optimal radiation fields and dose. We review and summarize the relevant studies for clinical references.
